imvaria, Inc.
IMVARIA Inc. is a pioneering health tech company specializing in AI-driven digital biomarker solutions for serious diseases, including lung fibrosis and interstitial lung disease (ILD). Founded in 2019 by physician-engineers from Google and Stanford University, the company aims to transform clinical decision-making into data science, enabling earlier and more accurate diagnoses while reducing invasive procedures. IMVARIA's solutions, such as Fibresolve and ScreenDx, are FDA-authorized AI tools that assist clinicians in non-invasive diagnosis and assessment of lung conditions, supporting better patient outcomes and healthcare efficiency.
Industries
Nr. of Employees
small (1-50)
imvaria, Inc.
Berkeley, California, United States, North America
Products
Fibresolve
A software-only AI diagnostic adjunct that analyzes lung CT imaging to provide a diagnostic subtype classification in suspected interstitial lung disease, intended for use by clinicians qualified in lung disease to support pre-invasive assessment of idiopathic pulmonary fibrosis.
ScreenDx
An automated background AI algorithm that analyzes CT imaging to detect interstitial lung findings compatible with interstitial lung disease and flag cases for referral workflows.
Bronchosolve (investigational)
Investigational AI tool under research to automate risk assessment for suspicious pulmonary nodules detected on screening CTs.
Fibresolve
A software-only AI diagnostic adjunct that analyzes lung CT imaging to provide a diagnostic subtype classification in suspected interstitial lung disease, intended for use by clinicians qualified in lung disease to support pre-invasive assessment of idiopathic pulmonary fibrosis.
ScreenDx
An automated background AI algorithm that analyzes CT imaging to detect interstitial lung findings compatible with interstitial lung disease and flag cases for referral workflows.
Bronchosolve (investigational)
Investigational AI tool under research to automate risk assessment for suspicious pulmonary nodules detected on screening CTs.
Services
Centralized AI Lab diagnostic service
Remote service that accepts de-identified clinical cases (imaging and lab data), runs automated ML analyses, and returns diagnostic reports to referring clinicians as an adjunct to clinical assessment.
Centralized AI Lab diagnostic service
Remote service that accepts de-identified clinical cases (imaging and lab data), runs automated ML analyses, and returns diagnostic reports to referring clinicians as an adjunct to clinical assessment.
Expertise Areas
- AI biomarker development
- Clinical imaging diagnostics for ILD and IPF
- SaMD development and commercialization
- Regulatory strategy for medical AI (De Novo and 510(k))
Key Technologies
- Deep learning and convolutional neural networks
- Multi-modal data fusion (imaging + labs + clinical data)
- CT image analysis and pattern recognition
- Cloud-based analytics and centralized processing